Master Decoder: A Profile of Kári Stefánsson

A neurologist by training, Stefánsson founded Iceland-based deCODE Genetics to explore what the human genome can tell us about disease and our species’ evolution.

head shot of blond woman wearing glasses
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Kári Stefánsson remembers exactly where he was when he formulated the idea for his company, deCODE Genetics. It was 1995, and he had recently moved from the University of Chicago to Harvard University. “I was sitting in Starbucks at the Beth Israel Hospital, and I put together this narrative for identifying genetic variants of a large number of diseases using data from a large number of people and also figuring out the structure of a population,” he says. “I proposed to do this in Iceland because the Icelandic population has the advantage of having started from a small number of colonizing individuals,” leading to what’s called a “founder effect.” He reasoned that because of this founder effect, the number of disease-associated genetic variants would be relatively small for each individual disease, so they’d be easier to identify among people in Iceland.

Stefánsson was a seasoned molecular biology and protein biochemistry ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky

    Anna Azvolinsky is a freelance science writer based in New York City.

Published In

March 2019

Going Under

Dissecting the effects of anesthetics

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide